A Tale of Two Companies in Open Heart
Six months ago, Heartport and CardioThoracic Systems were two new public companies with very similar stories to tell: both were capitalizing on booming interest in minimally-invasive techniques to do cardiac surgery and both saw their market caps reach impressive levels.
You may also be interested in...
Assessment work also isn’t slowing down, the new and generic drug office directors said in and interview, but approval data offers a note of concern.
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.